Mats Wahlström
Chairman
TriSalus Life Sciences, Inc. (TLSI)Board Member
TriSalus Life Sciences, Inc. (TLSI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mats Wahlström
Mats Wahlström is recorded as Chairman and Board Member at TriSalus Life Sciences, Inc. (TLSI). TriSalus Life Sciences, Inc. reported in an 8-K filed August 16, 2023 that Mats Wahlström was appointed Chairman of the New TriSalus Board, effective August 10, 2023. TriSalus Life Sciences, Inc. reported in an 8-K filed August 16, 2023 that Mats Wahlström was appointed director, effective August 10, 2023.
“The New TriSalus Board appointed Mr. Wahlström as Chairman of the New TriSalus Board.”
“Upon the Closing, each of Mary Szela, Sean Murphy, Mats Wahlström, Andrew von Eschenbach, George Kelly Martin, David J. Matlin, Arjun Desai, Kerry Hicks and Anil Singhal were elected to serve as directors on the New TriSalus Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-10–present
-
Current
2023-08-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TriSalus Life Sciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Mary Szela CEO, Board Member
- Karim Karti Chairman
- David B. Patience CFO
- David Patience CFO
- James Young CFO, Head of Investor Relations
- Andrew von Eschenbach Board Member
- Anil Singhal Board Member
- Arjun Desai Board Member
- Gary Gordon Board Member
- George Kelly Martin Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.